Explore All 1218 Growth Capital Business Services Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | July 22, 2022 |
| Target | Ephicacy |
| Sector | Business Services |
| Investor(s) | Great Point Partners |
| Deal Type | Growth Capital |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2003 |
| PE ASSETS | 1.7B USD |
| Size | Large |
| Type | Sector Focused |
Great Point Partners is a private investment firm focused on investing in private and public healthcare companies. Great Point's private equity practice invests $10 to $100 million of growth capital in private, growing companies. Specific areas of interest within the healthcare sector includes biotechnology and life sciences, consumer health, generic drugs, health care services, information technology, insurance, medical devices, specialty pharmaceuticals, and worker compensation companies. Great Point Partners was formed in 2003 and is based in Greenwich, Connecticut.
| Deal Context for Investor | # |
|---|---|
| Overall | 32 of 36 |
| Sector: Business Services | 2 of 2 |
| Type: Growth Capital | 5 of 6 |
| State: New Jersey | 1 of 1 |
| Country: United States | 26 of 28 |
| Year: 2022 | 4 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-01 |
SteriPack
Mullingar, Ireland SteriPack is a contract manufacturing and value-added service provider to the medical device and pharmaceutical (primarily drug-device combination products) industries. Serving some of the largest names in the medical device industry, the company has experienced impressive customer retention and provides the highest quality and customer service. SteriPack is headquartered in Mullingar, Ireland. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-29 |
iXCells Biotechnologies
San Diego, California, United States iXCells Biotechnologies is an innovative cell biology and cell technology company that provides preclinical drug discovery solutions with the focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities to accelerate the pace of drug discovery. iXCells offers customers access to high quality primary and iPSC derived cells, custom iPSC services, functional bioassay development and drug screening. iXCells Biotechnologies was founded in 2014 and is based in San Diego, California. |
Buy | - |
